Asma Deeb1, Khulood Khawaja2, Nida Sakrani2, Abdulla AlAkhras3, Ahmed Al Mesabi4, Ravi Trehan5, Palat Chirakkara Kumar6, Zahir Babiker4, Nico Nagelkerke7, Emmanuel Fru-Nsutebu4. 1. Division of Paediatric Endocrinology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. 2. Division of Paediatric Rheumatology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. 3. Internal Medicine Department, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. 4. Division of Infectious Diseases, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. 5. Division of Orthopaedic Surgery, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. 6. Division of Neurology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. 7. Public Health Institute, UAE University, Al Ain, UAE.
Abstract
BACKGROUND: The UAE reported its first cluster of COVID 2019 in a group of returned travellers from Wuhan in January 2020. Various comorbidities are associated with worse disease prognosis. Understanding the impact of ethnicity on the disease outcome is an important public health issue but data from our region is lacking. AIM: We aim to identify comorbidities among patients hospitalized for COVID-19 that are associated with inhospital death. Also, to assess if ethnicity is correlated with increased risk of death. Patients and Method. The study is a single-centre, observational study in Shaikh Shakhbout Medical City, Abu Dhabi. Patients admitted with COVID-19, between 1st of March and the end of May, were enrolled. Records were studied for demography, comorbidity, and ethnicity. Ethnicity was divided into Arabs (Gulf, North Africa, and the Levant), South Asia (India, Pakistan, Bangladesh, Nepal, and Afghanistan), Africans, the Philippines, and others. The study was approved by the Department of Health of Abu Dhabi. RESULTS: 1075 patients (972 males) were enrolled. There were 24 nationalities under 5 ethnicity groups. Mean (average) age was 51 years (20-81). 101 (9.4%) died with deceased patients being significantly older. Death risk was not significantly influenced by sex. Duration of hospitalization among survivors was 6.2 days (0.2-40.4) with older patients and men staying longer (P < 0.01). Comorbidities of diabetes, hypertension, cardiovascular disease, chronic renal disease, liver disease, and malignancy were associated with higher risk of mortality univariate, but only liver disease reached statistical significance after adjustment for age. The highest percentage of death was seen in Arab Levant (21.2) followed by the Asian Afghan (18.8); however, differences among ethnicities did not reach statistical significance (P = 0.086). CONCLUSION: COVID-19 outcome was worse in older people and those with comorbidities. Men and older patients required longer hospitalization. Ethnicity is not seen to impact the risk of mortality.
BACKGROUND: The UAE reported its first cluster of COVID 2019 in a group of returned travellers from Wuhan in January 2020. Various comorbidities are associated with worse disease prognosis. Understanding the impact of ethnicity on the disease outcome is an important public health issue but data from our region is lacking. AIM: We aim to identify comorbidities among patients hospitalized for COVID-19 that are associated with inhospital death. Also, to assess if ethnicity is correlated with increased risk of death. Patients and Method. The study is a single-centre, observational study in Shaikh Shakhbout Medical City, Abu Dhabi. Patients admitted with COVID-19, between 1st of March and the end of May, were enrolled. Records were studied for demography, comorbidity, and ethnicity. Ethnicity was divided into Arabs (Gulf, North Africa, and the Levant), South Asia (India, Pakistan, Bangladesh, Nepal, and Afghanistan), Africans, the Philippines, and others. The study was approved by the Department of Health of Abu Dhabi. RESULTS: 1075 patients (972 males) were enrolled. There were 24 nationalities under 5 ethnicity groups. Mean (average) age was 51 years (20-81). 101 (9.4%) died with deceased patients being significantly older. Death risk was not significantly influenced by sex. Duration of hospitalization among survivors was 6.2 days (0.2-40.4) with older patients and men staying longer (P < 0.01). Comorbidities of diabetes, hypertension, cardiovascular disease, chronic renal disease, liver disease, and malignancy were associated with higher risk of mortality univariate, but only liver disease reached statistical significance after adjustment for age. The highest percentage of death was seen in Arab Levant (21.2) followed by the Asian Afghan (18.8); however, differences among ethnicities did not reach statistical significance (P = 0.086). CONCLUSION: COVID-19 outcome was worse in older people and those with comorbidities. Men and older patients required longer hospitalization. Ethnicity is not seen to impact the risk of mortality.
Authors: Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti Journal: JAMA Date: 2020-04-28 Impact factor: 56.272
Authors: Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek Journal: EClinicalMedicine Date: 2020-11-12
Authors: Marta Colaneri; Paolo Sacchi; Valentina Zuccaro; Simona Biscarini; Michele Sachs; Silvia Roda; Teresa Chiara Pieri; Pietro Valsecchi; Antonio Piralla; Elena Seminari; Angela Di Matteo; Stefano Novati; Laura Maiocchi; Layla Pagnucco; Marcello Tirani; Fausto Baldanti; Francesco Mojoli; Stefano Perlini; Raffaele Bruno Journal: Euro Surveill Date: 2020-04
Authors: Judith Ju Ming Wong; Chin Seng Gan; Sanghvi Heli Kaushal; Soo Lin Chuah; Rehena Sultana; Natalie Woon Hui Tan; Kah Peng Eg; Koh Cheng Thoon; Jan Hau Lee; Chee Fu Yung Journal: Am J Trop Med Hyg Date: 2022-02-15 Impact factor: 2.345